High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting

BACKGROUND: High-dose (HD) chemotherapy with melphalan and autologous blood stem cell transplantation (ABSCT) for treatment of symptomatic multiple myeloma (MM) on an outpatient basis has been well established in the USA and Canada, whereas in Germany and Western Europe an inpatient setting is the c...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Lisenko, Katharina, Sauer, Sandra, Bruckner, Thomas, Egerer, Gerlinde, Goldschmidt, Hartmut, Hillengass, Jens, Schmier, Johann W., Shah, Sofia, Witzens-Harig, Mathias, Ho, Anthony D., Wuchter, Patrick
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5322605/
https://ncbi.nlm.nih.gov/pubmed/28228122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3137-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items